Zero complications
•
Zero
compromises
•
Zero inconsistency
How would your vascular access supplier respond
when challenged across these 4 critical
needs?
Infection Prevention 
Catheter Selection
Standards of Care
Improved Workflow
Want to learn more? We want to connect with you.
Request More Information Questions worth asking: What’s the best way to reduce the risk of central
line-associated bloodstream infections — and who can deliver it?
Teleflex antimicrobial impregnated catheters help you get closer to ZERO.1-4
Better procedures
Arrow®
pressure injectable central venous catheters (CVCs) can eliminate the need for an additional
vascular access device, saving you and your patients crucial time.
Proven safe and effective
The protection behind Arrowg+ard Blue
Plus® Catheters is chlorhexidine — a leading
worldwide broad-spectrum antiseptic — and silver sulfadiazine.1
Infection reduction
Arrowg+ard Blue
Plus® CVCs are proven to reduce CLABSI by 67-100%.1-4
Antimicrobial properties in Arrowg+ard Blue Plus® Catheters prevent bacteria from attaching, colonizing, and forming biofilm, providing stronger protection against CRBSI than Vantex and non-antimicrobial catheters.5
Proven over time with efficacy and safety verified by 30+ clinical studies. 6
Questions worth asking: How does your catheter protect our bottom line?
Protecting patients. Protecting profit.
Arrowg+ard Blue Plus® Catheters are proven to reduce CLABSI, thereby reducing the costs associated with treating infections7 — which can exceed $48,1008 per incident due to pharmacy charges, catheter changes, additional days in the ICU, lab tests, and extended hospital stays.
References:
- Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine of Central Catheter-Related Infections. Annals of Internal Medicine. 2005; 143: 570-80. Sponsored by Arrow (Teleflex).
- Lorente L, Lecuona M, Jimenez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. American Journal of Infection Control. 2014; 42: 321-4.
- Lorente L, Lecuona M, Jimenez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. American Journal of Infection Control. 2014; 42: 1130-2.
- Lorente L, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. American Journal of Infection Control. 2016; 44(12): 1526-29.
- Gupta N. Vascular AGB+ Biofilm formation comparison. Employed by Arrow International LLC (Teleflex). Sponsored by Arrow International LLC (Teleflex). MC-006839
- U.S. Renal Data System. USRDS 2016 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Kidney Diseases. 2016.
- O’Grady NP, Alexander M, Burns LA, et al. Guidelines for the Prevention of Intravascular Catheter-Related Infections, 2011 (Revised 2017). Atlanta, GA: Centers for Disease Control and Prevention; 2017.
- Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions. 2017. Agency for Healthcare Research and Quality, Rockville, MD. Available at: https://www.ahrq.gov/hai/pfp/haccost2017-results.html
Contraindications
The Arrowg+ard Blue® and Arrowg+ard Blue Plus® CVCs are contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.
Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.
Last updated 04/22 © 2022 Teleflex Incorporated. All rights reserved. MC-007264 Rev 1
Questions worth asking:Is there a single partner who can best offer the full
complement of catheters required to support all of our clinicians’ vascular access needs?
More is not just more.
More is better.
The Arrow® vascular access portfolio contains a comprehensive selection of catheters designed to accommodate a variety of insertion location and placement techniques to help you drive to ZERO. True Blue is True Choice.
Central line catheters: Maximize efficiency and satisfaction with solutions to suit all your vascular insertion needs.
Contraindications
The Arrowg+ard Blue® and Arrowg+ard Blue Plus® CVCs are contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.
Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.
Last updated 04/22 © 2022 Teleflex Incorporated. All rights reserved. MC-007264 Rev 1
Questions worth asking: Why should our central venous catheter inserters and
patients endure delay to therapy with a chest X-ray when a better solution for confirming
tip placement already exists?
Doing our part
with innovative products
Helping CVC inserters more easily hit their mark as a standard of practice.
Accurate, efficient, and safe
CVC placement
The Arrow® VPS Rhythm® Device provides ECG-based tip confirmation in a highly portable, lightweight, and versatile design. The system can be used in combination with many types of central venous catheters.
Eliminate the delay of confirmatory
chest X-rays
The Arrow® VPS Rhythm® Device is designed to work in harmony with your processes and procedures, allowing you to clear the line for use without the need for a confirmatory chest X-ray.*
* With appropriate hospital policy and procedure in place. See the VPS
Rhythm® Device Operator’s Manual or TipTracker™ Stylet Instructions for full Indications for
Use.
Bringing it all together with
Teleflex Academy
teleflex-academy.com
- Comprehensive and collaborative approach
- Engaging, enduring, evidence-based curriculum
- Courses created by accomplished instructors and industry leaders
- Range of hands-on/classroom, webinars, e-learning, and more
Your partner in process evaluation and
risk assessment
Arrow® OPERA Program
- On-site assessment
- Interviews (1-2 clinicians per unit)
- Summary meeting
- Follow-up as needed
Contraindications
The Arrowg+ard Blue® and Arrowg+ard Blue Plus® CVCs are contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.
Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, TipTracker, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.
Last updated 04/22 © 2022 Teleflex Incorporated. All rights reserved. MC-007264 Rev 1
Questions worth asking:What are the advantages of an all-in-one kit that can
be used across multiple catheter types?
Arrow® ErgoPack® Complete Kits are designed to help clinicians improve their workflow, standardize care, and improve patient safety with the added benefit of saving hospitals money.1-8
Improved procedures
A prepackaged kit like
Arrow® ErgoPack® Complete can help minimize procedure time and reduce
technical mistakes.1
Protection where you need it
Arrow®
ErgoPack® Complete Kits feature Arrowg+ard Blue Plus®
infection-prevention technology, while the MAC and PSI include Arrowg+ard Blue®
protection.
Standardized workflow drives efficiency
By
using Arrow® ErgoPack® Complete Kits across multiple vascular
insertion procedures, clinicians know what to expect every time, and training can be done
across multiple procedures in one session.
Questions worth asking:
How do Arrow® ErgoPack® Complete Kits benefit the clinician, the patient, and the hospital system?
How do Arrow® ErgoPack® Complete Kits benefit the clinician, the patient, and the hospital system?
Benefits for everyone
Upgrading to Arrow® ErgoPack® Complete Kits across CVC, MAC, and PSI can help prevent infection, improve workflow, and result in long-term cost savings, helping set your clinicians, patients, and health system up for success.1-8
References:
- Fenik Y, Celebi N, Wagner R, et al. Prepackaged central line kits reduce procedural mistakes during central line insertion: a randomized controlled prospective trial. BMC Medical Education. 2013;13:60. Published 2013 Apr 30. doi:10.1186/1472-6920-13-60.
- Claussen CD, Banzer D, Pfretzschner C, Kalender WA, Schörner W. Bolus geometry and dynamics after intravenous contrast medium injection. Radiology. 1984; 153 (2): 365 – 368.
- Plumb AA, Murphy G. The use of central venous catheters for intravenous contrast injection for CT examinations. The British journal of radiology. 2011. Mar; 84 (999): 197–203.
- Rupp ME, Lisco SJ, Lipsett PA, et al. Effect of a Second-Generation Venous Catheter Impregnated with Chlorhexidine and Silver Sulfadiazine of Central Catheter-Related Infections. Annals of Internal Medicine. 2005; 143: 570-80. Sponsored by Arrow (Teleflex).
- Lorente L, Lecuona M, Jimenez A, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters save costs. American Journal of Infection Control. 2014; 42: 321-4.
- Lorente L, Lecuona M, Jimenez A, et al. Cost/benefit analysis of chlorhexidine-silver sulfadiazine-impregnated venous catheters for femoral access. American Journal of Infection Control. 2014; 42: 1130-2.
- Lorente L, et al. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy. American Journal of Infection Control. 2016; 44(12): 1526-29.
- Abouleish, Youssef Z., Oldfield, Edward C., and Marik, Paul E. “Comparison of central-line-associated bloodstream infections between central venous catheters lined by combined chlorhexidine and silver sulfadiazine versus silver ionotrophes alone: A before-after-before retrospective study.” Infection Control & Hospital Epidemiology 2020: 1-3.
Contradictions
The Arrowg+ard Blue® and Arrowg+ard Blue Plus® CVCs are contraindicated for patients with known hypersensitivity to chlorhexidine, silver sulfadiazine and/or sulfa drugs.
Rx Only. CAUTION: Federal (USA) law restricts this device to sale by or on the order of a physician.
Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Plus, ErgoPack, and VPS Rhythm are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries. Other names may be trademarks of their respective owners.
Last updated 04/22
© 2022 Teleflex Incorporated. All rights reserved. MC-007264 Rev 1